Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Pericardial Drain Removal Safe Following Cardiac Tamponade

By Daniel Beris
Posted on 14 Dec 2016
After treating cardiac tamponade arising from atrial fibrillation (AF) catheter ablation, pericardial drains do not need to be kept in place for an additional day, according to a new study.

Researchers at John Radcliffe Hospital (Oxford, United Kingdom) conducted a retrospective descriptive analysis study of 43 cases of cardiac tamponade resulting from complication of atrial fibrillation catheter ablation (AFCA) procedures between 2006 and 2015 in order to examine the safety of early removal of pericardial drains. More...
The researcher compared 25 patients in whom the drain was removed early to 18 patients who underwent traditional delayed removal. Cardiac tamponade was diagnosed when pericardial effusion led to hypoperfusion and systolic blood pressure dropped below 80 mm Hg.

In cases that employed early removal strategy, the pericardial space was monitored for reaccumulation for a minimum of 30 minutes, with repeated transthoracic echocardiography. Once it reached dryness, the patient was deemed ready to leave the laboratory and the drain was left to operator discretion for removal. The delayed removal group was monitored for an extra 17 hours once no reaccumulation was confirmed. The main outcomes included need for repeat pericardiocentesis, major adverse outcomes, length of stay, and need for opiate analgesia.

The results showed that not one of the AF patients who had the drains taken out early needed repeat pericardiocentesis before hospital discharge. They also had a moderately shorter length of stay than their peers who had drain removal delayed in case of re-bleeding, and also went back on anticoagulation earlier. In addition, few patients with early removal needed opiate analgesia (8%) compared to the delayed removal group (72%). The study was published on November 15, 2016, in JACC: Clinical Electrophysiology.

“Early removal of pericardial drains after tamponade complicating atrial fibrillation catheter ablation procedures appears to be safe and effective, with re-insertion not required in this cohort,” concluded lead author Michala Pedersen, MD, and colleagues. “The traditional practice of leaving drains in situ for 12 to 24 hours may result in more patient discomfort and longer hospitalization. Additionally, there may be benefits to health economics.”

Cardiac tamponade occurs when fluid in the pericardium accumulates, resulting in compression of the heart. Symptoms typically include shortness of breath, weakness, lightheadedness, and cough. If fluid increases slowly the pericardial sac can expand to contain more than two liters; however, if the increase is rapid, as little as 200 mL can result in tamponade. When tamponade results in symptoms, drainage is necessary, by pericardiocentesis, a pericardial window, or a pericardiectomy. Tamponade due to AFCA is traditionally managed by pericardiocentesis with delayed removal of the drain (typically 12 to 24 hours later) in case of re-bleeding.

Related Links:
John Radcliffe Hospital


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.